Skip to content

Study using the App for Tinnitus Treatment in Patients with Tinnitus.

A Multicenter, Randomized, Double-Blind, Sham-Controlled Study using the App for Tinnitus Treatment in Patients with Tinnitus (Pilot Study).

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-jRCTs032230359
Enrollment
60
Registered
2023-09-25
Start date
2023-11-02
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic tinnitus with associated suffering

Interventions

Treatment group: App content for 16 weeks. Control group: App content for 16 weeks.

Sponsors

Wasano Koichiro
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1)Outpatients between 18 and 75 years of age at the time of obtaining consent (regardless of gender). 2)Patients with clinically diagnosed chronic unilateral or bilateral tinnitus. 3)Patients who own a smartphone or other device that meets the required OS version (iOS 14.0 or higher, Android 6.0 or higher) and agree to use it for this study. 4)Patients who speak Japanese on a daily basis and determined to have sufficient reading comprehension ability to use the study app by the principal investigator.

Exclusion criteria

Exclusion criteria: 1)Patients with middle ear disease (otitis media, otosclerosis, eustachian tube dysfunction, etc.)or acute hearing loss necessitating treatment. 2)Patients scheduled for or requiring hospitalization or surgical procedures with anesthesia during the study period. 3)Patients with a history of severe psychiatric disorders, (such as severe depression, suicidal ideation, or suicide attempts) or with depression or other psychiatric disorders that are uncontrolled with current medication at certain doses. 4)Patients with clinically significant cardiac, renal, hepatic, vascular, pulmonary, gastrointestinal, endocrine, neurologic, hematology, or metabolic disorders.

Design outcomes

Primary

MeasureTime frame
Change in THI total score from week 0 at week 16 after study app prescription.

Secondary

MeasureTime frame
THI score TFI score NRS score HADS depression score HADS anxiety score AIS score PGI-I score

Contacts

Public ContactKoichiro Wasano

Tokai University Hospital

wasano@tokai.ac.jp+81-463-93-1211

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026